Your 90-Day AR Analysis is complimentary - See your true collection gap.

Trusted Wound Care Billing Services in Delaware

Published Date - Apr 02, 2026 Modified Date - Apr 02, 2026 7 min read
Trusted Wound Care Billing Services in Delaware

Delaware wound care providers are facing a billing environment unlike anything from five years ago — and wound care billing services in Delaware have never demanded more precision. The CY 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F) reset skin substitute reimbursement to a flat rate of $127.14 per square centimeter.

The ICD-10 code T81.32XA — used widely for post-surgical wound dehiscence — was deleted and replaced with four depth-specific codes. And Novitas Solutions, the Medicare Administrative Contractor (MAC) covering Delaware, is actively conducting Targeted, Probe and Educate (TPE) audits on wound care claims under LCD L35125.

If your facility’s billing infrastructure wasn’t built specifically for wound care, 2026 is going to be expensive.

Wound care billing services in Delaware require more than clean claim submission. They require deep familiarity with Novitas documentation requirements, payer-specific authorization protocols, and the coding precision that keeps facilities out of post-payment audit exposure.

Why Delaware Wound Care Billing Is Getting Harder

Let’s be direct about what’s changed. Three regulatory forces are compressing margins for Delaware wound care centers right now.

The skin substitute reset

Effective January 1, 2026, CMS reclassified non-biological skin substitutes as incident-to supplies. The previous Average Sales Price methodology is gone. Every claim now faces a flat payment rate — and Novitas’s existing LCD L35125 remains the active coverage standard following CMS’s December 24, 2025 withdrawal of proposed replacement LCDs.

What that means for Delaware providers: documentation requirements haven’t loosened. Novitas still expects four-week conventional treatment documentation, wound measurement consistency, and vascular assessment for DFU and VLU claims. Generic RCM vendors filing Delaware claims without this specificity are generating denials on almost every skin substitute encounter.

The ICD-10 depth-specificity shift

Claims still carrying T81.32XA are denying automatically. Delaware wound care facilities treating post-surgical dehiscence must now bill T81.320A (deep internal), T81.321A (superficial), T81.322A (intraabdominal), or T81.329A (unspecified) — each with appropriate encounter designators. A single coder applying the wrong depth code costs a facility $800 to $2,400 per claim in write-offs before anyone notices the pattern.

Payer tightening outside the WISeR pilot

Delaware is not a WISeR Model pilot state. But commercial payers — including Highmark BCBS Delaware, the dominant commercial carrier in the state — are mirroring CMS’s documentation scrutiny in their own prior authorization criteria.

Diamond State Health Plan routes through Highmark and Molina Healthcare, each with distinct auth rules. A wound care billing operation treating Delaware Medicaid as a single payer environment is generating avoidable denials on nearly every other claim.

This is the billing environment your facility is operating in right now.

What MBC’s Wound Care Billing Services in Delaware Deliver

MBC has operated a dedicated wound care billing operation for over 26 years. Our wound care billers are trained specifically on Novitas LCD L35125, CPT coding for debridement (11042–11047, 97597–97598), NPWT (97605–97608 with correct reusable vs. disposable split), MIST therapy (97610), and skin substitute application (15271–15278).

Here’s what that looks like operationally for Delaware facilities:

Service Area What MBC Delivers
Novitas LCD Compliance Documentation audited against L35125 criteria before claim submission
Skin Substitute Coding Flat-rate claims filed with correct product category and modifier usage
NPWT Billing Reusable vs. disposable split applied correctly; DME MAC routing handled
ICD-10 Depth Coding T81.320A–T81.329A applied based on clinical documentation, not assumption
Payer-Specific Auth Separate workflows for Highmark, Molina, and Diamond State Health Plan
Denial Management Root-cause analysis within 48 hours; appeal submitted within MAC deadline

Our average Delaware wound care client sees a 94–97% first-pass clean claim rate within 90 days of onboarding. Days in AR reduce by an average of 22% within the first two billing cycles.

Delaware Wound Care Facilities We Serve

MBC provides wound care billing services in Delaware across every major market. Whether your facility is in a dense referral corridor or serving a rural patient population, our billers are actively managing wound care claims in these cities and surrounding communities:

Wilmington — Dover — Newark — Middletown — Bear — Glasgow — Hockessin — Pike Creek — Smyrna — Milford — Georgetown — Seaford — Lewes — Rehoboth Beach — Harrington — Milford — Laurel — Elsmere — New Castle — Brookside — Claymont — Edgemoor — Rising Sun-Lebanon — Bridgeville — Millsboro — Ocean View — Selbyville — Fenwick Island — Milton — Blades

If your facility is treating diabetic foot ulcers, venous leg ulcers, pressure injuries, or post-surgical dehiscence anywhere in Delaware — we are already billing in your market.

The Revenue Diagnostic: Your First 90 Days with MBC

Before any engagement, MBC conducts a 90-Day Revenue Diagnostic specific to your wound care operation. We audit your last 90 days of claims against Novitas LCD L35125 requirements, identify undercoded debridement encounters, flag skin substitute claims with missing documentation, and calculate the dollar value of recoverable revenue.

Most Delaware wound care facilities discover between $85,000 and $240,000 in recoverable revenue in the first audit alone.

This is not a soft sales conversation. It is a line-by-line claim review — and it costs you nothing to find out what you’re leaving on the table.

Request Your 90-Day Revenue Diagnostic.

FAQs

Q1. What makes wound care billing services in Delaware different from general medical billing?

Wound care billing in Delaware operates under Novitas Solutions LCD L35125, which sets specific medical necessity criteria for debridement, NPWT, MIST therapy, and skin substitute application. General billing vendors don’t maintain Novitas-specific documentation workflows, which is why most facilities using generic RCM partners see denial rates 15–25% higher on wound care claims than specialty-focused billing operations deliver. Delaware’s payer complexity — Highmark BCBS, Molina, and Diamond State Health Plan each with distinct auth requirements — adds another layer most general billers aren’t equipped to handle.

Q2. How does the CY 2026 flat reimbursement rate for skin substitutes affect Delaware wound care centers?

The CY 2026 PFS Final Rule (CMS-1832-F) set a flat payment rate of $127.14 per square centimeter for non-biological skin substitutes, replacing the previous Average Sales Price methodology. For Delaware providers, this means revenue per application is now fixed — the only lever left to protect margin is documentation completeness and coding accuracy. Novitas’s existing LCD remains active following the December 2025 withdrawal of the proposed replacement LCDs, so documentation requirements are unchanged. Facilities that don’t have precise clinical documentation workflows are leaving significant reimbursement on the table.

Q3. Which Delaware cities does MBC serve for wound care billing?

MBC covers every wound care market in Delaware — from Wilmington and Newark in the north to Dover, Milford, Georgetown, Seaford, and the coastal communities of Lewes, Rehoboth Beach, Fenwick Island, and Ocean View in the south. If your facility treats wound care patients in Delaware, we are actively managing claims in your market.

Q4. What CPT codes does MBC handle for wound care billing in Delaware?

Our wound care billers manage the full CPT spectrum — debridement codes 11042 through 11047 and 97597 through 97598 (billed by tissue depth removed, not wound depth), NPWT codes 97605 through 97608 (with correct reusable vs. disposable DME routing), MIST therapy code 97610, and skin substitute application codes 15271 through 15278. We also handle HCPCS supply codes, modifier application, and NCCI bundle conflict resolution — particularly CPT 29580 bundling rules when strapping is performed on the same anatomic site as debridement.

Q5. How quickly can MBC identify revenue leakage in our current wound care billing operation?

Our 90-Day Revenue Diagnostic typically identifies recoverable revenue within the first two weeks of claim review. We audit against Novitas LCD L35125 requirements, flag ICD-10 depth-coding errors (including T81.32XA claims that should have been transitioned to the T81.320A–T81.329A series), and calculate payer-specific denial patterns. Most Delaware facilities discover $85,000–$240,000 in recoverable revenue in the first audit.

Trusted Wound Care Billing Services in Delaware

Phone: 888-357-3226
Email: sales@medicalbillersandcoders.com

Related Posts

888-357-3226